Literature DB >> 26934620

Opioid use and walking among patients with chronic low back pain.

Sarah L Krein1, Amy Bohnert, Hyungjin Myra Kim, Meredith E Harris, Caroline R Richardson.   

Abstract

This study examined the effect of a walking intervention on step counts among patients with chronic back pain who report opioid use. Data were collected as part of a randomized trial to reduce back-pain-related disability. Participants (n = 118 usual care, 111 intervention) were Veterans receiving care within one healthcare system. Step counts were collected at baseline, 6 mo, and 12 mo via an uploading pedometer. Self-reported opioid use was collected by survey. More than 40% (n = 99) of participants reported opioid use at baseline. After adjustment, the predicted mean step count for baseline opioid users assigned to the intervention increased by more than 1,200 steps compared with a reduction of nearly 400 steps for those assigned to usual care (between-group difference = 1,625 steps, p = 0.004). Among nonopioid users, there was no change for those in the intervention (-16 steps) and an increase of about 660 steps for those assigned to usual care (between-group difference = 683 steps, p = 0.17). These data show that patients taking opioids may engage in walking to help manage their back pain. This finding emphasizes the importance of encouraging the use of alternative pain management strategies for these patients.

Entities:  

Keywords:  Veterans; chronic back pain; exercise therapy; objective measurement; opioids; pain management; pain-related disability; pedometer; step counts; walking

Mesh:

Substances:

Year:  2016        PMID: 26934620     DOI: 10.1682/JRRD.2014.08.0190

Source DB:  PubMed          Journal:  J Rehabil Res Dev        ISSN: 0748-7711


  1 in total

1.  The role of social isolation in physical and emotional outcomes among patients with chronic pain.

Authors:  Sarah Bannon; Jonathan Greenberg; Ryan A Mace; Joseph J Locascio; Ana-Maria Vranceanu
Journal:  Gen Hosp Psychiatry       Date:  2021-01-28       Impact factor: 3.238

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.